Application analysis of humanistic care-based continuous nursing on patients with soft tissue sarcoma
- PMID: 40587725
- PMCID: PMC12212795
- DOI: 10.1097/MD.0000000000042810
Application analysis of humanistic care-based continuous nursing on patients with soft tissue sarcoma
Abstract
To observe the application of humanistic care-based continuous nursing in patients with soft tissue sarcoma (STS), aiming to improve the overall benefit level of patients. Retrospective analysis was used to collect the clinical data of 30 patients with STS who received routine care mode from January 2021 to January 2022 and included in the routine group, and the clinical data of 30 patients with STS who received humanistic care-based continuous nursing from February 2022 to February 2023 and included in the research group. Two groups were compared in psychological status [Zung Self-rating Anxiety Scale (SAS) and Zung Self-rating Depression Scale (SDS)], coping style [Simplified Coping Style Questionnaire], self-management efficacy [Chinese - Strategies Used by People to Promote Health (C-SUPPH)], medication compliance [Morisky Medication Adherence Scale (MMAS-8)], and hope level [Herth Hope Index (HHI)]. There was no significant difference in the SAS, SDS, Simplified Coping Style Questionnaire, C-SUPPH, MMAS-8, and HHI score between the 2 groups in pre-nursing (P > .05). The SAS, SDS, and negative coping style score of the 2 groups in post-nursing were reduced, the positive coping style, C-SUPPH, MMAS-8, and HHI score of the 2 groups were increased, and the research group changed significantly (P < .05). The humanistic care-based continuous nursing can effectively improve the anxiety, depression, and other negative emotions of patients with STS, help patients to establish a positive attitude towards coping styles, improve the level of self-efficacy and medication compliance, and enhance the level of hope of patients to overcome the disease.
Keywords: continuous nursing; coping styles; humanistic care; negative emotions; self-efficacy level; soft tissue sarcoma.
Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
References
-
- Mailankody S, Kumar VS, Khan SA, et al. Resource-appropriate selection of osteosarcoma treatment protocols in low- and middle-income countries. Pediatr Blood Cancer. 2022;69:29540. - PubMed
-
- Alemi F, Malakoti F, Vaghari-Tabari M, et al. DNA damage response signaling pathways as important targets for combination therapy and chemotherapy sensitization in osteosarcoma. J Cell Physiol. 2022;237:2374–86. - PubMed
-
- Sridharan K, Paul E, Stirling RG, Li C. Impacts of multidisciplinary meeting case discussion on palliative care referral and end-of-life care in lung cancer: A retrospective observational study. Intern Med J. 2021;51:1450–6. - PubMed
-
- Kosmin M, Padhani AR, Gogbashian A, et al. Comparison of Whole-Body MRI,CT, and bone scintigraphy for response evaluation of cancer therapeutics in metastatic breast cancer to bone. Radiology. 2020;297:622–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical